CD22, Human (Inotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD22, Human (Inotuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD22, Human (Inotuzumab biosimilar)
CloneInotuzumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD22 Recombinant Antibody (Inotuzumab). Inotuzumab ozogamicin, sold under the brand name Besponsa, is an antibody-drug conjugate medication used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Immunogenn/a
Other NamesAnti-CD22 Recombinant Antibody, Research Grade Inotuzumab, Anti-Human CD22 Recombinant Antibody(Inotuzumab), CMC-544, Antibody Drug Analogues, Monoclonal Antibody, YR1170, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 635715-01-4
Catalog #YR1170
Priceplease inquire
Order / More InfoCD22, Human (Inotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.